Abstract:Melatonin is uncommonly effective in reducing oxidative stress under a remarkably large number of circumstances. It achieves this action via a variety of means: direct detoxification of reactive oxygen and reactive nitrogen species and indirectly by stimulating antioxidant enzymes while suppressing the activity of pro-oxidant enzymes. In addition to these well-described actions, melatonin also reportedly chelates transition metals, which are involved in the Fenton/Haber-Weiss reactions; in doing so, melatonin reduces the formation of the devastatingly toxic hydroxyl radical resulting in the reduction of oxidative stress. Melatonin's ubiquitous but unequal intracellular distribution, including its high concentrations in mitochondria, likely aid in its capacity to resist oxidative stress and cellular apoptosis. There is credible evidence to suggest that melatonin should be classified as a mitochondria-targeted antioxidant. Melatonin's capacity to prevent oxidative damage and the associated physiological debilitation is well documented in numerous experimental ischemia/reperfusion (hypoxia/reoxygenation) studies especially in the brain (stroke) and in the heart (heart attack). Melatonin, via its antiradical mechanisms, also reduces the toxicity of noxious prescription drugs and of methamphetamine, a drug of abuse. Experimental findings also indicate that melatonin renders treatment-resistant cancers sensitive to various therapeutic agents and may be useful, due to its multiple antioxidant actions, in especially delaying and perhaps treating a variety of age-related diseases and dehumanizing conditions. Melatonin has been effectively used to combat oxidative stress, inflammation and cellular apoptosis and to restore tissue function in a number of human trials; its efficacy supports its more extensive use in a wider variety of human studies. The uncommonly high-safety profile of melatonin also bolsters this conclusion. It is the current feeling of the authors that, in view of the widely diverse beneficial functions that have been reported for melatonin, these may be merely epiphenomena of the more fundamental, yet-to-be identified basic action(s) of this ancient molecule.

Progress on the role of melatonin in resisting oxidative stress

Melatonin as a natural ally against oxidative stress: a physicochemical examination

Actions of Melatonin in the Reduction of Oxidative Stress

Melatonin as an antioxidant: under promises but over delivers

Melatonin: a Well‐documented Antioxidant with Conditional Pro‐oxidant Actions

Melatonin as a powerful antioxidant

Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes

Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review

Mitochondria: Central Organelles for Melatonin′s Antioxidant and Anti-Aging Actions

Melatonin ameliorates ischemic-like injury-evoked nitrosative stress: Involvement of HtrA2/PED pathways in endothelial cells.

Molecular Mechanisms of Melatonin-Mediated Cell Protection and Signaling in Health and Disease

Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions

Melatonin as a therapeutic agent for alleviating endothelial dysfunction in cardiovascular diseases: Emphasis on oxidative stress

Is Melatonin the Cornucopia of the 21st Century?

Evaluating the Oxidative Stress in Inflammation: Role of Melatonin

Melatonin: A Versatile Protector against Oxidative DNA Damage

Melatonin as an Antioxidant Agent in Stroke: An Updated Review.

Melatonin As Potential Targets for Delaying Ovarian Aging.

Melatonin Decreases Neurovascular Oxidative/nitrosative Damage and Protects Against Early Increases in the Blood-Brain Barrier Permeability after Transient Focal Cerebral Ischemia in Mice.

Melatonin reverses H2 O2 -induced premature senescence in mesenchymal stem cells via the SIRT1-dependent pathway.

N-Acetylserotonin and 6-Hydroxymelatonin against Oxidative Stress: Implications for the Overall Protection Exerted by Melatonin